ArticleJournal of cancer research and clinical oncology2021

Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer.

Wanting Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.